• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News  
Title Created Date
Cancer research: Are the drugs we count on based on bad science? 27 October 2013
How effective is chemo therapy? 07 October 2013
Long-term side-effects. Molecularly targeted therapies hold promise for many pediatric cancers, but at what cost? 19 July 2013
Are we treating cancer, but killing the patient? 06 April 2013
Radiation generates cancer stem cells from less aggressive breast cancer cells! 22 February 2013
Melatonin's role in cancer 17 January 2013
Chemo can backfire, make cancer worse! 12 December 2012
Display # 

Search

Follow us...

Latest

  • Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
  • Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats
  • Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis
  • Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines
  • Targeting Growth Hormone Receptor to Overcome Therapy Resistance in Non-Small Cell Lung Cancer
  • Dopamine D2 Receptor Agonists as Modulators of VEGF-A-Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities
  • [68Ga]Ga-DOTA-TOC positron emission tomography outperforms [18F]FDOPA and [18F]FDG PET in pediatric neuroblastoma imaging: a prospective study
  • Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis
  • Melatonin protects rat liver against irradiation-induced oxidative injury
  • Hormonal signaling in glioblastoma: emerging roles in stemness and tumor plasticity
  • Melatonin Modulation of Radiation-Induced Molecular Changes in MCF-7 Human Breast Cancer Cells
  • Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair
  • Combined TP53 Codon 72 Genotype and p53 Expression in Association with Vitamin D Benefit in Digestive Tract Cancer: A Post-Hoc Study of the AMATERASU Trial
  • Melatonin as an anti-inflammatory agent in radiotherapy
  • Melatonin as a Radio-Sensitizer in Cancer
  • Somatostatin in oncology, the overlooked evidences
  • Prolactin inhibitors in oncology
  • Vitamin D potentiates STING agonist-induced antitumor immunity in NSCLC

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Bibliography
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • How effective is chemo therapy?
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Vademecum
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer